These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21122622)

  • 1. The disparity between the very strong performance of high-density lipoprotein (HDL) cholesterol as a risk factor and the very weak effects. Foreword.
    Brown WV
    J Clin Lipidol; 2010; 4(1):1. PubMed ID: 21122622
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of disease: HDL metabolism as a target for novel therapies.
    Rader DJ
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):102-9. PubMed ID: 17245404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modification of lipoprotein metabolism. A new era].
    Masana Marín L
    Rev Clin Esp; 1990 Mar; 186(4):149-50. PubMed ID: 2367714
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
    Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
    Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL cholesterol: physiology, pathophysiology, and management.
    Link JJ; Rohatgi A; de Lemos JA
    Curr Probl Cardiol; 2007 May; 32(5):268-314. PubMed ID: 17481993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE gene polymorphisms and response to statin therapy.
    Zintzaras E; Kitsios GD; Triposkiadis F; Lau J; Raman G
    Pharmacogenomics J; 2009 Aug; 9(4):248-57. PubMed ID: 19529002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of hypothyroidism on plasma lipoprotein metabolism].
    Hayashi H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():172-6. PubMed ID: 11347052
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of exercise on plasma high-density lipoprotein cholesteryl ester metabolism in male and female miniature swine.
    von Duvillard SP; Foxall TL; Davis WP; Terpstra AH
    Metabolism; 2000 Jul; 49(7):826-32. PubMed ID: 10909990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein metabolism: potential therapeutic targets.
    Davidson MH; Toth PP
    Am J Cardiol; 2007 Dec; 100(11 A):n32-40. PubMed ID: 18047851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, apoproteins and a case of a drug trial that did not fulfil expectations.
    Dominiczak MH
    Curr Opin Lipidol; 2007 Oct; 18(5):603-6. PubMed ID: 17885434
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for extralysosomal hydrolysis of high-density lipoprotein cholesteryl esters in rat hepatoma cells (Fu5AH): a model for delivery of high-density lipoprotein cholesterol.
    DeLamatre JG; Carter RM; Hornick CA
    J Cell Physiol; 1991 Jan; 146(1):18-24. PubMed ID: 1990016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid modification in type 2 diabetes: the role of LDL and HDL.
    Vergès B
    Fundam Clin Pharmacol; 2009 Dec; 23(6):681-5. PubMed ID: 19650852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
    McKenney JM; Barnett MD; Wright JT; Proctor JP
    Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.
    Jafri H; Alsheikh-Ali AA; Karas RH
    J Am Coll Cardiol; 2010 Jun; 55(25):2846-54. PubMed ID: 20579542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
    Grover SA; Dorais M; Coupal L
    Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells.
    Gonçalves RP; Rodrigues DG; Maranhão RC
    Leuk Res; 2005 Aug; 29(8):955-9. PubMed ID: 15978947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.